BioHealth News Archive

GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics | 2013 | Press releases | Media | GlaxoSmithKline

GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics | 2013 | Press releases | Media | GlaxoSmithKline

GlaxoSmithKline (GSK) plc and the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), have…

Read More
Entrepreneur Of The Year® Awards Ceremony – Ernst & Young LLP

Entrepreneur Of The Year® Awards Ceremony – Ernst & Young LLP

Our world needs entrepreneurs Their ability to innovate, to inspire others, to power a business along the difficult journey from start-up to market leader…

Read More
Should I Join an Accelerator? – Business Insider

Should I Join an Accelerator? – Business Insider

Today is Demo Day for Techstars Boston.  I love Techstars Demo Days for many reasons, not the least of which is the amazing community…

Read More
Debunking Myths About Biotech Venture Capital – Forbes

Debunking Myths About Biotech Venture Capital – Forbes

There are lots of myths about venture capital and biotech in particular, as noted previously on this blog.  Many of these myths are deeply…

Read More
Glaxo to Get Up to $200 Million From U.S. for Biothreat Research – Businessweek

Glaxo to Get Up to $200 Million From U.S. for Biothreat Research – Businessweek

GlaxoSmithKline Plc (GSK), the U.K.’s largest drugmaker, will work with the U.S. government to develop antibiotics for resistant infections and bioterrorist threats in an…

Read More
GSK creates competition for academic researchers – Philadelphia Business Journal

GSK creates competition for academic researchers – Philadelphia Business Journal

GlaxoSmithKline has created a contest for academic researchers that it hopes will accelerate the speed by which academic research can be turned into novel…

Read More
Request for Comment on Proposed Methods for Avoiding Duplication, Redundancy and Competition With Industry Activities

Request for Comment on Proposed Methods for Avoiding Duplication, Redundancy and Competition With Industry Activities

The Public Health Service Act indicates that the purpose of the National Center for Advancing Translational Sciences (NCATS) is to advance translational sciences by…

Read More
For startups, health care reform is a huge opportunity, HHS tech guy says | VentureBeat

For startups, health care reform is a huge opportunity, HHS tech guy says | VentureBeat

The Affordable Care Act, aka health care reform, aka Obamacare, is spurring a massive creation of new business opportunities. So says Bryan Sivak, the…

Read More
Q&A with Tech Council of Maryland’s new chairman – Baltimore Business Journal

Q&A with Tech Council of Maryland’s new chairman – Baltimore Business Journal

Doug Doerfler, CEO of Gaithersburg-based MaxCyte Inc., was this month named the Tech Council of Maryland's new chairman. He steps into the position with…

Read More
Health IT adoption doubles from 2012 | Healthcare IT News

Health IT adoption doubles from 2012 | Healthcare IT News

More than half of all eligible providers nationwide have received federal incentive payments for demonstrating meaningful use of electronic health records, rates that have…

Read More
StartRight! Women’s Business Plan Competition by the Maryland Women’s Business Center

StartRight! Women’s Business Plan Competition by the Maryland Women’s Business Center

The StartRight! Women's Business Plan Competition was founded in 2003 by Rockville Economic Development Inc. (REDI) to encourage and support women’s entrepreneurship. Currently in…

Read More
NY Digital Health Accelerator Is a Model to Emulate: Startup’s Perspective – Forbes

NY Digital Health Accelerator Is a Model to Emulate: Startup’s Perspective – Forbes

Zina Moukheiber said the New York Digital Health Accelerator Is a Model to Emulate at the beginning of the program. With the proliferation of accelerators, I…

Read More
N. Va. biotech has always been weak. How that could change. – Washington Business Journal

N. Va. biotech has always been weak. How that could change. – Washington Business Journal

Biotech has never quite taken flight in Northern Virginia. Whether that's due to the lack of a big corporate anchor or blue-chip research university,…

Read More
U.S. Entrepreneurship Rates Reach Highest Level In More Than A Decade – Babson College

U.S. Entrepreneurship Rates Reach Highest Level In More Than A Decade – Babson College

Optimistic and confident in their abilities, a diverse and growing percentage of U.S. citizens engage in entrepreneurship, according to the Global Entrepreneurship Monitor (GEM).…

Read More
United Therapeutics spoofs ‘Goodnight Moon’ in annual report – Washington Business Journal

United Therapeutics spoofs ‘Goodnight Moon’ in annual report – Washington Business Journal

The threshold for reporting on marketing stunts is a high one, and United Therapeutics Corp. has just cleared it. Reaching us by mail today…

Read More